Diabetes Research and Clinical Practice
Volume 87, Issue 3 , Pages 302-312 , March 2010

Diabetes and depression: Global perspectives

  • Leonard E. Egede

      Affiliations

    • Department of Medicine, Center for Health Disparities Research, Medical University of South Carolina, Charleston, SC, United States
    • Center for Disease Prevention and Health Interventions for Diverse Populations, Ralph H. Johnson VA Medical Center, Charleston, SC, United States
    • Corresponding Author InformationCorresponding author at: Medical University of South Carolina, Center for Health Disparities Research, 135 Rutledge Avenue, Room 280H, Charleston, SC 29425, United States. Tel.: +1 843 792 2969; fax: +1 843 876 1201.
    • ,
  • Charles Ellis

      Affiliations

    • Center for Disease Prevention and Health Interventions for Diverse Populations, Ralph H. Johnson VA Medical Center, Charleston, SC, United States
    • Department of Health Professions, Medical University of South Carolina, Charleston, SC, United States

Received 24 September 2009 ,Accepted 25 January 2010.

References 

  1. International Diabetes Federation . Diabetes Atlas. 4th ed.. Brussels: International Diabetes Federation; 2009;
  2. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections. Diabetes Care. 1998;21(9):1414–1431
  3. International Diabetes Federation, The human, social and economic impact of diabetes. Available at: http://www.idf.org/home/index.cfm?node=41. 2008.
  4. Egede LE. Disease-focused or integrated treatment: diabetes and depression. Med. Clin. North Am. 2006;90(4):627–646
  5. Greden JF. Physical symptoms of depression: unmet needs. J. Clin. Psychiatry. 2003;64(Suppl. 7):5–11
  6. World Health Organization, Revised global burden of disease (GBD) 2002 estimates. Available from: http://www.who.int/healthinfo/bodgbd2002revised/en/index.html. 2005.
  7. Ustun TB, Ayuso-Mateos JL, Chatterji S, Mathers C, Murray CJ. Global burden of depressive disorders in the year 2000. Br. J. Psychiatry. 2004;184:386–392
  8. Lin EH, Korff MV, Alonso J, Angermeyer MC, Anthony J, Bromet E, et al. Mental disorders among persons with diabetes--results from the World Mental Health Surveys. J. Psychosom. Res. 2008;65(6):571–580
  9. Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA. 2003;289(23):3095–3105
  10. Alonso J, Angermeyer MC, Bernert S, Bruffaerts R, Brugha TS, Bryson H, et al. Prevalence of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta. Psychiatr. Scand. Suppl. 2004;420:21–27
  11. Demyttenaere K, Bruffaerts R, Posada-Villa J, Gasquet I, Kovess V, Lepine JP, et al. Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization World Mental Health Surveys. JAMA. 2004;291(21):2581–2590
  12. Michaud CM, Murray CJ, Bloom BR. Burden of disease—implications for future research. JAMA. 2001;285(5):535–539
  13. US Department of Health and Human Services, Mental health: a report of the surgeon general Rockville, MD: US Department of Health and Human Services, Substance Abuse and Mental Health Services, Substance Abuse and Mental Health Services Administration, Center for Mental Health Services, National Institutes of Health, National Institute of Mental Health, 1999.
  14. American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders. Fourth ed. 2000, Text Revision (DSM-IV-TR). Washington, DC: American Psychiatric Association.
  15. Spitzer RL, Williams JB, Kroenke K, Linzer M, deGuy FVr, Hahn SR, et al. Utility of a new procedure for diagnosing mental disorders in primary care. The PRIME-MD 1000 study. JAMA. 1994;272(22):1749–1756
  16. Beck A, Ward C, Mendelson M. An inventory for measuring depression. Arch. Gen. Psychiatry. 1961;4:53–63
  17. Zung W. A self-rating depression scale. Arch. Gen. Psychiatry. 1965;12:63–70
  18. Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl. Psychol. Meas. 1977;1:385–401
  19. Whooley MA, Avins AL, Miranda J, Browner WS. Case-finding instruments for depression. Two questions are as good as many. J. Gen. Intern. Med. 1997;12:439–445
  20. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J. Gen. Intern. Med. 2001;16(9):606–613
  21. U.S. Preventative Services Task Force (USPSTF) . Screening for depression: recommendations and rationale. J. Gen. Intern. Med. 2002;136(10):760–764
  22. Willis T. Diabetes: A Medical Odyssey. New York: Tuckahoe; 1971;
  23. Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care. 2001;24(6):1069–1078
  24. Li C, Ford ES, Strine TW, Mokdad AH. Prevalence of depression among U.S. adults with diabetes: findings from the 2006 behavioral risk factor surveillance system. Diabetes Care. 2008;31(1):105–107
  25. Li C, Ford ES, Zhao G, Ahluwalia IB, Pearson WS, Mokdad AH. Prevalence and correlates of undiagnosed depression among U.S. adults with diabetes: the Behavioral Risk Factor Surveillance System. Diabetes Res Clin Pract. 2009;83(2):268–279
  26. Asghar S, Hussain A, Ali SM, Khan AK, Magnusson A. Prevalence of depression and diabetes: a population-based study from rural Bangladesh. Diabet. Med. 2007;24(8):872–877
  27. Sotiropoulos A, Papazafiropoulou A, Apostolou O, Kokolaki A, Gikas A, Pappas S. Prevalence of depressive symptoms among non insulin treated Greek type 2 diabetic subjects. BMC Res. Notes. 2008;1:101
  28. Zahid N, Asghar S, Claussen B, Hussain A. Depression and diabetes in a rural community in Pakistan. Diabetes Res. Clin. Pract. 2008;79(1):124–127
  29. Khamseh ME, Baradaran HR, Rajabali H. Depression and diabetes in Iranian patients: a comparative study. Int. J. Psychiatry Med. 2007;37(1):81–86
  30. Almawi W, Tamim H, Al-Sayed N, Arekat MR, Al-Khateeb GM, Baqer A, et al. Association of comorbid depression, anxiety, and stress disorders with Type 2 diabetes in Bahrain, a country with a very high prevalence of Type 2 diabetes. J. Endocrinol. Invest. 2008;31(11):1020–1024
  31. Mier N, Bocanegra-Alonso A, Zhan D, Wang S, Stoltz SM, Acosta-Gonzalez RI, et al. Clinical depressive symptoms and diabetes in a binational border population. J. Am. Board Fam. Med. 2008;21(3):223–233
  32. Kogan SM, Brody GH, Crawley C, Logan P, Murry VM. Correlates of elevated depressive symptoms among rural African American adults with type 2 diabetes. Ethn. Dis. 2007;17(1):106–112
  33. Gary TL, Crum RM, Cooper-Patrick L, Ford D, Brancati FL. Depressive symptoms and metabolic control in African-Americans with type 2 diabetes. Diabetes Care. 2000;23(1):23–29
  34. Ali S, Stone MA, Peters JL, Davies MJ, Khunti K. The prevalence of co-morbid depression in adults with Type 2 diabetes: a systematic review and meta-analysis. Diabet. Med. 2006;23(11):1165–1173
  35. Knol MJ, Twisk JW, Beekman AT, Heine RJ, Snoek FJ, Pouwer F. Depression as a risk factor for the onset of type 2 diabetes mellitus. A meta-analysis. Diabetologia. 2006;49(5):837–845
  36. Mezuk B, Eaton WW, Albrecht S, Golden SH. Depression and type 2 diabetes over the lifespan: a meta-analysis. Diabetes Care. 2008;31(12):2383–2390
  37. Golden SH, Lazo M, Carnethon M, Bertoni AG, Schreiner PJ, Roux AV, et al. Examining a bidirectional association between depressive symptoms and diabetes. JAMA. 2008;299(23):2751–2759
  38. Musselman DL, Betan E, Larsen H, Phillips LS. Relationship of depression to diabetes types 1 and 2: epidemiology, biology, and treatment. Biol. Psychiatry. 2003;54(3):317–329
  39. Talbot F, Nouwen A. A review of the relationship between depression and diabetes in adults: is there a link?. Diabetes Care. 2000;23(10):1556–1562
  40. Saydah SH, Brancati FL, Golden SH, Fradkin J, Harris MI. Depressive symptoms and the risk of type 2 diabetes mellitus in a US sample. Diabetes Metab. Res. Rev. 2003;19:202–208
  41. Palinkas LA, Barrett-Connor E, Wingard DL. Type 2 diabetes and depressive symptoms in older adults: a population-based study. Diabet. Med. 1991;8(6):532–539
  42. Lustman PJ, Anderson RJ, Freedland KE, de Groot M, Carney RM, Clouse RE. Depression and poor glycemic control: a meta-analytic review of the literature. Diabetes Care. 2000;23(7):934–942
  43. Richardson LK, Egede LE, Mueller M, Echols CL, Gebregziabher M. Longitudinal effects of depression on glycemic control in veterans with Type 2 diabetes. Gen. Hosp. Psychiatry. 2008;30(6):509–514
  44. Wagner JA, Abbott GL, Heapy A, Yong L. Depressive symptoms and diabetes control in African Americans. J. Immigr. Minor. Health. 2009;11(1):66–70
  45. Van Tilburg MA, McCaskill CC, Lane JD, Edwards CL, Bethel A, Feinglos MN, et al. Depressed mood is a factor in glycemic control in type 1 diabetes. Psychosom. Med. 2001;63(4):551–555
  46. Egede LE. Effect of depression on self-management behaviors and health outcomes in adults with type 2 diabetes. Curr. Diabetes Rev. 2005;1:235–243
  47. Gonzalez S, Safren SA, Delahanty LM, Cagliero E, Wexler DJ, Meigs JB, et al. Symptoms of depression prospectively predict poorer self-care in patients with Type 2 diabetes. Diabet. Med. 2008;25(9):1102–1107
  48. Gonzalez JS, Peyrot M, McCarl LA, Collins EM, Serpa L, Mimiaga MJ, et al. Depression and diabetes treatment nonadherence: a meta-analysis. Diabetes Care. 2008;31(12):2398–2403
  49. Cramer JA. A systematic review of adherence with medications for diabetes. Diabetes Care. 2004;27(5):1218–1224
  50. Lin EH, Katon W, Von Korff M, Rutter C, Simon GE, Oliver M, et al. Relationship of depression and diabetes self-care, medication adherence, and preventive care. Diabetes Care. 2004;27(9):2154–2160
  51. Gonzalez JS, Safren SA, Cagliero E, Wexler DJ, Delahanty L, Wittenberg E, et al. Depression, self-care, and medication adherence in type 2 diabetes: relationships across the full range of symptom severity. Diabetes Care. 2007;30(9):2222–2227
  52. Egede LE, Ellis C. The effects of depression on diabetes knowledge, diabetes self-management, and perceived control in indigent patients with type 2 diabetes. Diabetes Technol. Ther. 2008;10(3):213–219
  53. de Groot M, Anderson R, Freedland KE, Clouse RE, Lustman PJ. Association of depression and diabetes complications: a meta-analysis. Psychosom. Med. 2001;63(4):619–630
  54. Clouse RE, Lustman PJ, Freedland KE, Griffith LS, McGill JB, Carney RM. Depression and coronary heart disease in women with diabetes. Psychosom. Med. 2003;65(3):376–383
  55. Roy MS, Roy A, Affouf M. Depression is a risk factor for poor glycemic control and retinopathy in African-Americans with type 1 diabetes. Psychosom. Med. 2007;69(6):537–542
  56. Sahota PK, Knowler WC, Looker HC. Depression, diabetes, and glycemic control in an American Indian community. J. Clin. Psychiatry. 2008;69(5):800–809
  57. Gross R, Olfson M, Gameroff MJ, Carasquillo O, Shea S, Feder A, et al. Depression and glycemic control in Hispanic primary care patients with diabetes. J. Gen. Intern. Med. 2005;20(5):460–466
  58. Black SA, Markides KS, Ray LA. Depression predicts increased incidence of adverse health outcomes in older Mexican Americans with type 2 diabetes. Diabetes Care. 2003;26(10):2822–2828
  59. Egede LE. Diabetes, major depression, and functional disability among U.S. adults. Diabetes Care. 2004;27(2):421–428
  60. Egede LE. Effects of depression on work loss and disability bed days in individuals with diabetes. Diabetes Care. 2004;27(7):1751–1753
  61. Eren I, Erdi O, Sahin M. The effect of depression on quality of life of patients with type II diabetes mellitus. Depress. Anxiety. 2008;25(2):98–106
  62. Grandy S, Chapman RH, Fox KM. Quality of life and depression of people living with type 2 diabetes mellitus and those at low and high risk for type 2 diabetes: findings from the Study to Help Improve Early evaluation and management of risk factors Leading to Diabetes (SHIELD). Int. J. Clin. Pract. 2008;62(4):562–568
  63. Le TK, Able SL, Lage MJ. Resource use among patients with diabetes, diabetic neuropathy, or diabetes with depression. Cost Eff. Resour. Alloc. 2006;4:18
  64. Ciechanowski PS, Katon WJ, Russo JE. Depression and diabetes: impact of depressive symptoms on adherence, function, and costs. Arch. Intern. Med. 2000;160(21):3278–3285
  65. Finkelstein EA, Bray JW, Chen H, et al. Prevalence and costs of major depression among elderly claimants with diabetes. Diabetes Care. 2003;26(2):415–420
  66. Nichols L, Barton PL, Glazner J, McCollum M. Diabetes, minor depression and health care utilization and expenditures: a retrospective database study. Cost Eff. Resour. Alloc. 2007;5:4
  67. Egede LE, Zheng D, Simpson K. Comorbid depression is associated with increased health care use and expenditures in individuals with diabetes. Diabetes Care. 2002;25(3):464–470
  68. Zhang X, Norris SL, Gregg EW, Cheng YJ, Beckles G, Kahn HS. Depressive symptoms and mortality among persons with and without diabetes. Am. J. Epidemiol. 2005;161(7):652–660
  69. Katon W, Fan MY, Unutzer J, et al. Depression and diabetes: a potentially lethal combination. J. Gen. Intern. Med. 2008;23(10):1571–1575
  70. Egede LE, Nietert PJ, Zheng D. Depression and all-cause and coronary heart disease mortality among adults with and without diabetes. Diabetes Care. 2005;28(6):1339–1345
  71. Egede LE. Failure to recognize depression in primary care: issues and challenges. J. Gen. Intern. Med. 2007;22(5):701–703
  72. Lustman PJ, Griffith LS, Clouse RE, Freedland KE, Eisen SA, Rubin EH, et al. Effects of nortriptyline on depression and glycemic control in diabetes: results of a double-blind, placebo-controlled trial. Psychosom. Med. 1997;59(3):241–250
  73. Lustman PJ, Freedland KE, Griffith LS, Clouse RE. Fluoxetine for depression in diabetes: a randomized double-blind placebo-controlled trial. Diabetes Care. 2000;23(5):618–623
  74. Williams JW, Katon W, Lin EH, Noel PH, Worchel J, Cornell J, et al. The effectiveness of depression care management on diabetes-related outcomes in older patients. Ann. Intern. Med. 2004;140(12):1015–1024
  75. Wang MY, Tsai PS, Chou KR, Chen CM. A systematic review of the efficacy of non-pharmacological treatments for depression on glycaemic control in type 2 diabetics. J. Clin. Nurs. 2008;17(19):2524–2530
  76. Lustman PJ, Griffith LS, Freedland KE, Kissel SS, Clouse RE. Cognitive behavior therapy for depression in type 2 diabetes mellitus. A randomized, controlled trial. Ann. Intern. Med. 1998;129(8):613–621
  77. Katon WJ, Von Korff M, Lin EH, Simon G, Ludman E, Russo J, et al. The Pathways Study: a randomized trial of collaborative care in patients with diabetes and depression. Arch. Gen. Psychiatry. 2004;61(10):1042–1049
  78. Snoek FJ, van der Ven NC, Twisk JW, Hogenelst MH, Tromp-Wever AM, van der Ploeg HM, et al. Cognitive behavioural therapy (CBT) compared with blood glucose awareness training (BGAT) in poorly controlled Type 1 diabetic patients: long-term effects on HbA moderated by depression. A randomized controlled trial. Diabet. Med. 2008;25(11):1337–1342
  79. Petrak F, Herpertz S. Treatment of depression in diabetes: an update. Curr. Opin. Psychiatry. 2009;22(2):211–217
  80. Simon GE, Katon WJ, Lin EH, et al. Cost-effectiveness of systematic depression treatment among people with diabetes mellitus. Arch. Gen. Psychiatry. 2007;64(1):65–72
  81. Katon WJ, Russo JE, Von Korff M, Lin EH, Ludman E, Ciechanowski PS. Long-term effects on medical costs of improving depression outcomes in patients with depression and diabetes. Diabetes Care. 2008;31(6):1155–1159
  82. Ludman EJ, Katon W, Russo J, Von Korff M, Simon G, Ciechanowski P, et al. Depression and diabetes symptom burden. Gen. Hosp. Psychiatry. 2004;26(6):430–436
  83. Adriaanse MC, Dekker JM, Spijkerman AM, Twisk JW, Nijpels G, van der Ploeg HM, et al. Diabetes-related symptoms and negative mood in participants of a targeted population-screening program for type 2 diabetes: the Hoorn Screening Study. Qual. Life Res. 2005;14(6):1501–1509
  84. Nutting PA, Rost K, Dickinson M, Werner JJ, Dickinson P, Smith JL, et al. Barriers to initiating depression treatment in primary care practice. J Gen Intern. Med. 2002;17(2):103–111
  85. IDF Clinical Guidelines Task Force, Global guideline for Type 2 diabetes. 2005, Brussels: International Diabetes Federation.

PII: S0168-8227(10)00047-1

doi: 10.1016/j.diabres.2010.01.024

Diabetes Research and Clinical Practice
Volume 87, Issue 3 , Pages 302-312 , March 2010

Article Tools

* Image Usage & Resolution